Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Shalby Ltd

NSE: SHALBY · BSE: 540797 · Healthcare · 38 announcements

Share price
₹134.62
Market cap
₹1,454 Cr
Revenue (annual)
₹1,141 Cr
Net profit (annual)
₹37.39 Cr
P/E (TTM)
37.0×Sector 53.1×
Promoter holding
74.33%+0.00% QoQ
FII holding
4.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10:53 IST BSE
Other Announcement

Shalby Other Announcement

Shalby Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall compliance with SEBI regulations and guidelines.

16:55 IST NSE
Employee Stock Options

Shalby Employee Stock Options

Shalby Limited announced that an employee exercised 7,000 stock options at ₹10 per share, totaling ₹0.007 Crore. The shares will be transferred from the secondary market via the Employee Welfare Trust, resulting in no change to the company's paid-up equity share capital.

Value
₹0.01 Cr
19:08 IST NSE
Management Change

Shalby Management Change

Mr. Vijay Kishanlal Kedia has resigned as an Independent Director of Shalby Limited, effective April 30, 2026. He cited increasing professional commitments and time constraints as reasons for stepping down. The company placed on record its appreciation for his contributions. He confirmed there are no other material reasons for his departure.

17:14 IST BSE
Debt & Borrowing

Shalby Debt & Borrowing: ₹120.3 Cr

Shalby Limited confirmed it does not qualify as a 'Large Corporate' for the year ended March 31, 2026, under SEBI norms. The company reported outstanding borrowings of ₹120.32 Crore. Consequently, mandatory incremental borrowing requirements through debt securities are not applicable to the company for this period.

Value
₹120.3 Cr
18:38 IST BSE
Regulatory Approval

Shalby Regulatory Approval

Shalby Ltd's Krishna unit in Ahmedabad received regulatory approval to perform Kidney Transplants for five years, effective April 9, 2026. This milestone enables the facility to offer comprehensive, life-saving local transplant services, enhancing continuity of care and reducing travel needs for patients in the surrounding community.

Execution
5 years
18:30 IST NSE
Legal & Regulatory

Shalby Legal & Regulatory

Shalby Limited received an order from the ITAT, Ahmedabad, demanding ₹4.14 Crore. The demand relates to a pre-demerger tax dispute involving share premiums disallowed under Section 68. The company intends to contest the order at appropriate forums and reasonably expects a favorable outcome.

Value
₹4.14 Cr
15:16 IST NSE
Debt & Borrowing

Shalby Debt & Borrowing: ₹122.1 Cr

Shalby Limited has issued a Standby Letter of Credit (SBLC) for ₹122.08 Crore (USD 13.27 Million) through IndusInd Bank Limited. This guarantee supports its US-based step-down subsidiary, Shalby Advanced Technologies, Inc., in obtaining credit facilities. The company foresees no material financial or operational impact from this contingent liability.

Value
₹122.1 Cr